Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar 19;308(6931):756-9.
doi: 10.1136/bmj.308.6931.756.

Longitudinal study of outcome of chronic fatigue syndrome

Affiliations

Longitudinal study of outcome of chronic fatigue syndrome

A Wilson et al. BMJ. .

Abstract

Objective: To examine the predictors of long term outcome for patients with the chronic fatigue syndrome.

Design: Cohort study.

Subjects: 139 subjects previously enrolled in two treatment trials; 103 (74%) were reassessed a mean of 3.2 years after start of the trials.

Setting: University hospital referral centre.

Main outcome measures: Age at onset, duration of illness, psychological and immunological status at initial assessment. Ongoing symptom severity, levels of disability, and immunological function at follow up.

Results: 65 subjects had improved but only six reported no current symptoms. An alternative medical diagnosis had been made in two and psychiatric illness diagnosed in 20. The assignment of a primary psychiatric diagnosis at follow up and the strength of the belief that a physical disease process explained all symptoms at entry to the trials both predicted poor outcome. Age at onset of illness, duration of illness, neuroticism, premorbid psychiatric diagnoses, and cell mediated immune function did not predict outcome.

Conclusion: Though most patients with the chronic fatigue syndrome improve, a substantial proportion remain functionally impaired. Psychological factors such as illness attitudes and coping style seem more important predictors of long term outcome than immunological or demographic variables.

PubMed Disclaimer

Comment in

References

    1. Psychol Rep. 1990 Feb;66(1):39-48 - PubMed
    1. BMJ. 1992 Jul 18;305(6846):147-52 - PubMed
    1. Lancet. 1991 Sep 21;338(8769):707-12 - PubMed
    1. Ann Allergy. 1984 Feb;52(2):75-82 - PubMed
    1. Ann Intern Med. 1985 Jan;102(1):7-16 - PubMed

Publication types

MeSH terms

Substances